| Product Code: ETC12953742 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The India multiple sclerosis market import shipment exhibited robust growth with a notable CAGR from 2020 to 2024. The market further accelerated between 2023 and 2024, indicating strong momentum and a significant expansion trend during the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Multiple Sclerosis Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Multiple Sclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 India Multiple Sclerosis Market - Industry Life Cycle |
3.4 India Multiple Sclerosis Market - Porter's Five Forces |
3.5 India Multiple Sclerosis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Multiple Sclerosis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 India Multiple Sclerosis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 India Multiple Sclerosis Market Revenues & Volume Share, By Symptom Management, 2021 & 2031F |
3.9 India Multiple Sclerosis Market Revenues & Volume Share, By Stage, 2021 & 2031F |
4 India Multiple Sclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of multiple sclerosis in India |
4.2.2 Growing healthcare infrastructure and access to advanced treatment options |
4.2.3 Rising healthcare expenditure and insurance coverage for neurological disorders |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for multiple sclerosis treatment |
4.3.2 High cost of disease-modifying therapies and treatment options |
4.3.3 Challenges in accurate diagnosis and monitoring of multiple sclerosis progression |
5 India Multiple Sclerosis Market Trends |
6 India Multiple Sclerosis Market, By Types |
6.1 India Multiple Sclerosis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Multiple Sclerosis Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Multiple Sclerosis Market Revenues & Volume, By Relapsing-Remitting MS, 2021 - 2031F |
6.1.4 India Multiple Sclerosis Market Revenues & Volume, By Secondary Progressive MS, 2021 - 2031F |
6.1.5 India Multiple Sclerosis Market Revenues & Volume, By Primary Progressive MS, 2021 - 2031F |
6.1.6 India Multiple Sclerosis Market Revenues & Volume, By Clinically Isolated Syndrome, 2021 - 2031F |
6.1.7 India Multiple Sclerosis Market Revenues & Volume, By Pediatric MS, 2021 - 2031F |
6.2 India Multiple Sclerosis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 India Multiple Sclerosis Market Revenues & Volume, By MRI, 2021 - 2031F |
6.2.3 India Multiple Sclerosis Market Revenues & Volume, By Lumbar Puncture, 2021 - 2031F |
6.2.4 India Multiple Sclerosis Market Revenues & Volume, By Evoked Potentials, 2021 - 2031F |
6.2.5 India Multiple Sclerosis Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.2.6 India Multiple Sclerosis Market Revenues & Volume, By Neurological Exam, 2021 - 2031F |
6.3 India Multiple Sclerosis Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 India Multiple Sclerosis Market Revenues & Volume, By Immunomodulators, 2021 - 2031F |
6.3.3 India Multiple Sclerosis Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.3.4 India Multiple Sclerosis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.3.5 India Multiple Sclerosis Market Revenues & Volume, By Occupational Therapy, 2021 - 2031F |
6.3.6 India Multiple Sclerosis Market Revenues & Volume, By Disease-Modifying Therapies, 2021 - 2031F |
6.4 India Multiple Sclerosis Market, By Symptom Management |
6.4.1 Overview and Analysis |
6.4.2 India Multiple Sclerosis Market Revenues & Volume, By Fatigue Management, 2021 - 2031F |
6.4.3 India Multiple Sclerosis Market Revenues & Volume, By Pain Relief, 2021 - 2031F |
6.4.4 India Multiple Sclerosis Market Revenues & Volume, By Muscle Spasticity, 2021 - 2031F |
6.4.5 India Multiple Sclerosis Market Revenues & Volume, By Cognitive Therapy, 2021 - 2031F |
6.4.6 India Multiple Sclerosis Market Revenues & Volume, By Emotional Support, 2021 - 2031F |
6.5 India Multiple Sclerosis Market, By Stage |
6.5.1 Overview and Analysis |
6.5.2 India Multiple Sclerosis Market Revenues & Volume, By Early Stage, 2021 - 2031F |
6.5.3 India Multiple Sclerosis Market Revenues & Volume, By Progressive Stage, 2021 - 2031F |
6.5.4 India Multiple Sclerosis Market Revenues & Volume, By Advanced Stage, 2021 - 2031F |
6.5.5 India Multiple Sclerosis Market Revenues & Volume, By Late Stage, 2021 - 2031F |
6.5.6 India Multiple Sclerosis Market Revenues & Volume, By Pediatric Stage, 2021 - 2031F |
7 India Multiple Sclerosis Market Import-Export Trade Statistics |
7.1 India Multiple Sclerosis Market Export to Major Countries |
7.2 India Multiple Sclerosis Market Imports from Major Countries |
8 India Multiple Sclerosis Market Key Performance Indicators |
8.1 Number of clinical trials and research studies focused on multiple sclerosis in India |
8.2 Adoption rate of emerging therapies and treatment options for multiple sclerosis |
8.3 Patient satisfaction and outcomes measures following multiple sclerosis treatment |
9 India Multiple Sclerosis Market - Opportunity Assessment |
9.1 India Multiple Sclerosis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Multiple Sclerosis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 India Multiple Sclerosis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 India Multiple Sclerosis Market Opportunity Assessment, By Symptom Management, 2021 & 2031F |
9.5 India Multiple Sclerosis Market Opportunity Assessment, By Stage, 2021 & 2031F |
10 India Multiple Sclerosis Market - Competitive Landscape |
10.1 India Multiple Sclerosis Market Revenue Share, By Companies, 2024 |
10.2 India Multiple Sclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here